Dr. Annelou de Vries (the Netherlands)
An introduction and current challenges in transgender care for adolescents
There are concerns about whether the care for transgender youth is sufficiently evidence-based, about explanations for the increase in demand for care, and about whether the currently offered care model is also effective for newer or different presentations of gender diversity compared to previous years. Adolescent transgender care is a relatively new field that is rapidly developing. It includes early medical intervention and is at present the internationally dominant care model. Currently, serious threats to providing early affirming medical care exist in the USA, Europe and Australia. In Europe especially, the evidence base of the model is debated leading to adaptations in national guidelines, while in the US legal regulations have led to closure of clinics and banning the provision of transgender care for minors. In this presentation, I will discuss the history and rationale behind the introduction of puberty blockers and the provision of medical gender-affirming treatment for minors, current clinical practice and existing controversies, as well as future obstacles and opportunities.